Kratom-Associated Ventricular Fibrillation
暂无分享,去创建一个
[1] E. Walter,et al. Death from Kratom toxicity and the possible role of intralipid , 2018, Journal of the Intensive Care Society.
[2] O. Grundmann. Patterns of Kratom use and health impact in the US-Results from an online survey. , 2017, Drug and alcohol dependence.
[3] Mei Lan Tan,et al. Mitragynine and its potential blocking effects on specific cardiac potassium channels. , 2016, Toxicology and applied pharmacology.
[4] Oliver Grundmann,et al. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse , 2015, International Journal of Legal Medicine.
[5] M. Shoaib,et al. Discriminative stimulus properties of mitragynine (kratom) in rats , 2015, Psychopharmacology.
[6] W. Shim,et al. Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes , 2014, PloS one.
[7] Walter C. Prozialeck,et al. Pharmacology of Kratom: An Emerging Botanical Agent With Stimulant, Analgesic and Opioid-Like Effects , 2012, The Journal of the American Osteopathic Association.
[8] Z. Aziz,et al. Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. , 2012, Journal of ethnopharmacology.
[9] L. Mcwhirter,et al. A Case Report of Inpatient Detoxification after Kratom (Mitragyna speciosa) Dependence , 2010, European Addiction Research.